[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

2017-2021 US HIV/AIDS Diagnostics Market Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot

February 2017 | 60 pages | ID: U4C8EDDA896EN
Venture Planning Group

US$ 810.00 US$ 900.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This DataPack presents the US test volume and sale forecasts for HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory assays performed in the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Blood Banks
  • Public Health Labs
  • Physician Offices
The DataPack provides sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche.

Contains 60 pages and 7 tables
Major Companies Developing or Marketing AIDS Tests
USA: HIV or HIV1/2/Comb      Test Volume and Sales Forecast by Market Segment
USA: HIV Ag Test Volume and Sales Forecast by Market Segment
USA: Western Blot/Other Confirmatory Tests Volume and Sales Forecast By Market Segment
USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
USA: AIDS Diagnostics Market by Major Supplier
USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers

More Publications

2015 UK HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot - Blood Banks, Commercial Labs, Hospitals, Public Health Labs - Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review US$ 1,840.00 October 2015 251 pages
2016-2020 UK HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot-Blood Banks, Commercial Labs, Hospitals, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review US$ 1,840.00 March 2016 251 pages
2016-2020 EU5 HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot-Blood Banks, Commercial Labs, Hospitals, Public Health Labs-Supplier Shares, Competitive Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures, Innovative Technologies, Instrumentation Review US$ 3,160.00 March 2016 277 pages
2017-2021 UK HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures US$ 2,070.00 January 2017 251 pages
2017-2021 US HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures US$ 2,070.00 January 2017 250 pages

Need Help?

Ask a Question

Market Reports

All Categories